ArticleOncotarget2017

Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine.

Cheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.